US regulators are ‘very concerned’ about the side effects of AstraZeneca’s vaccine

US regulators are ‘very concerned’ about the potential side effects of AstraZeneca and Oxford University’s coronavirus vaccine and are debating whether or not to allow the trials to resume. Last week, the trial was put on hold when a British participant was rushed to the hospital after suffering a serious reaction that triggered spinal cord … Read more

Oxford and AstraZeneca’s COVID vaccine trial could restart ‘within days’

Trials of Oxford University’s coronavirus vaccine could be allowed to restart just days after a British volunteer was rushed to hospital with suspected swelling in their spinal cord. UK drug giant AstraZeneca, which owns the rights to the vaccine, announced that all studies of the jab had been paused indefinitely while it investigates whether the … Read more

AstraZeneca’s COVID-19 vaccine trials put on hold after suspected ‘serious’ reaction

BREAKING: Oxford and AstraZeneca’s COVD-19 vaccine trials put on a hold after a UK participant had a ‘serious’ suspected reaction to the leading shot candidate Late stage trials for the vaccine being developed by AstraZeneca and Oxford University have been put on hold  A ‘serious adverse event,’ a possible reaction to the shot was reported … Read more

British drugs giant Astrazeneca’s shares hit record highs

British drugs giant Astrazeneca’s shares hit record highs as it vies with Unilever to be country’s most valuable listed business By Daily Mail City & Finance Reporter Published: 21:50 BST, 24 July 2020 | Updated: 22:07 BST, 24 July 2020 British drugs giant Astrazeneca is having a good year.  Its shares have hit record highs … Read more

Results of Astrazeneca’s Covid-19 vaccine trial due ‘within weeks’

Moment of truth for Astrazeneca: Results of UK drug firm’s Covid-19 vaccine trial due ‘within weeks’ By Matt Oliver For The Daily Mail Published: 21:50 BST, 25 May 2020 | Updated: 22:04 BST, 25 May 2020 Astrazeneca’s bid to produce the world’s first Covid-19 vaccine is facing a moment of truth, with results from a … Read more